trending Market Intelligence /marketintelligence/en/news-insights/trending/SlJ9-4tHYk--M9TKzMhQYA2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

William Blair grows biopharma coverage, names co-group heads in equity research

Blog

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Video

Climate Credit Analytics: Linking climate scenarios to financial impacts

Blog

Banking Essentials Newsletter: May Edition

Blog

Global M&A Infographic Q1 2021


William Blair grows biopharma coverage, names co-group heads in equity research

William Blair & Co. LLC is expanding biopharmaceuticals coverage in its equity research and institutional sales and trading teams.

In line with the increased focus, the company reorganized its healthcare equity research coverage into two groups: biopharmaceuticals and healthcare technology. It named Tim Lugo and Katherine Xu co-group heads of the biopharmaceuticals equity research team and will promote Andy Hsieh, Matt Phipps and Raju Prasad to senior research analysts. In addition, Amanda Murphy will expand her existing biopharmaceuticals and diagnostic services equity research coverage to include companies focused on gene sequencing and gene editing technologies.

In institutional sales and trading, William Blair promoted John Mullaly to global healthcare coverage specialist.